NCT00695669View on ClinicalTrials.gov

A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64

PHASE2CompletedINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

June 5, 2008

Primary Completion Date

August 13, 2008

Study Completion Date

January 8, 2009

Conditions
Influenza
Interventions
BIOLOGICAL

Influenza A (H5N1) Virus Monovalent Vaccine

Two doses administered intramuscularly (IM), the first in the deltoid region of the non-dominant arm and the second in the deltoid region of the dominant arm.

Trial Locations (3)

P3E 6C3

GSK Investigational Site, Greater Sudbury

M9W 4L6

GSK Investigational Site, Toronto

G1W 4R4

GSK Investigational Site, Québec

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00695669 - A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64 | Biotech Hunter | Biotech Hunter